Aurobindo Pharma gets USFDA nod for generic antidepressant tablets

The company has received the final approval from the US Food and Drug Administration (USFDA) to manufacture and market Fluoxetine tablets in the strengths of 10 mg and 20 mg, Aurobindo Pharma said in a filing to BSE. The tablets are generic version of Eli Lilly's Prozac tablets, it added. The product will be launched in April 2020.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news